AIxCrypto Holdings (AIXC)
NASDAQ:AIXC
Want to see AIXC full AI Analyst Report?
Top Page
AIxCrypto Holdings
(NASDAQ:AIXC)
Select Model
Select Model
Rating:46Neutral
Price Target:
$1.50
▼(-43.40% Downside)
Action:Reiterated
Date:06/24/26
The score is held down primarily by very weak financial performance (no revenue, sizable and worsening losses, and ongoing cash burn). Technicals are neutral with modest short-term stabilization but a weaker long-term trend versus the 200-day average, while valuation is constrained by losses and no dividend. Corporate events add both potential upside (new platforms and added funding flexibility) and meaningful execution/dilution risk, resulting in an overall below-average score.
Positive Factors
Low leverage / stronger capital base
Minimal debt and a materially larger equity base provide durable financial flexibility during the strategic transition. Low leverage reduces solvency and covenant risk, enabling the company to fund product development and partnerships without immediate refinancing pressure, supporting execution over coming quarters.
Negative Factors
Pre-revenue and widening losses
The company remains pre-revenue with sharply larger TTM losses, indicating the business model has not yet produced sustainable sales. Persisting negative profitability materially increases reliance on external capital, risks equity dilution, and makes achieving self-funded growth unlikely without rapid commercial traction.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / stronger capital base
Minimal debt and a materially larger equity base provide durable financial flexibility during the strategic transition. Low leverage reduces solvency and covenant risk, enabling the company to fund product development and partnerships without immediate refinancing pressure, supporting execution over coming quarters.
Read all positive factors
AIxCrypto Holdings (AIXC) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$21.85M
Dividend YieldN/A
Average Volume (3M)2.38M
Price to Earnings (P/E)―
Beta (1Y)2.07
Revenue GrowthN/A
EPS Growth41.17%
CountryUS
Employees4
SectorTechnology
Sector Strength88
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)-10.23
Shares Outstanding20,234,993
10 Day Avg. Volume295,576
30 Day Avg. Volume2,383,814
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.20
Price to Sales (P/S)0.00
P/FCF Ratio-0.24
Enterprise Value/Market Cap0.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-11.16
Enterprise Value/Ebitda-0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AIxCrypto Holdings Business Overview & Revenue Model
Company Description
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quad...
AIxCrypto Holdings Financial Statement Overview
Summary
Income Statement
10
Very Negative
Balance Sheet
38
Negative
Cash Flow
16
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.65M |
| Gross Profit | -105.58K | 0.00 | 0.00 | 0.00 | -12.16K | 1.32M |
| EBITDA | -19.48M | -15.98M | -5.24M | -10.95M | -13.84M | -22.32M |
| Net Income | -20.40M | -16.97M | -6.26M | -13.42M | -18.64M | -17.90M |
Balance Sheet | ||||||
| Total Assets | 23.90M | 31.28M | 4.69M | 2.03M | 19.08M | 22.84M |
| Cash, Cash Equivalents and Short-Term Investments | 6.20M | 19.33M | 1.17M | 401.80K | 3.17M | 17.54M |
| Total Debt | 0.00 | 142.24K | 0.00 | 1.30M | 1.76M | 1.68M |
| Total Liabilities | 2.03M | 3.33M | 2.01M | 4.14M | 10.32M | 6.27M |
| Stockholders Equity | 21.87M | 27.95M | 2.68M | -2.10M | 7.24M | 16.56M |
Cash Flow | ||||||
| Free Cash Flow | -9.86M | -23.54M | -6.33M | -10.30M | -13.57M | -14.87M |
| Operating Cash Flow | -9.86M | -6.95M | -6.33M | -10.30M | -13.25M | -14.73M |
| Investing Cash Flow | -24.08M | -15.88M | -1.91M | 4.22M | -183.76K | -141.36K |
| Financing Cash Flow | 40.11M | 40.99M | 9.01M | -550.00K | 2.91M | 8.43M |
AIxCrypto Holdings Technical Analysis
2.65
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AIXC, the sentiment is undefined. The current price of 2.65 is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a undefined sentiment for AIXC.
AIxCrypto Holdings Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
Performance Comparison
AIxCrypto Holdings Corporate Events
Business Operations and StrategyProduct-Related Announcements
AIxCrypto Unveils RoboShare Platform and Autonomous Network
Positive
Jun 23, 2026
On June 22, 2026, AIxCrypto Holdings debuted at Automate 2026 in Chicago, using North America’s largest automation and robotics exhibition to showcase its growing role in autonomous systems. The company launched RoboShare, a matchmaking plat...
Business Operations and StrategyPrivate Placements and Financing
AIxCrypto Secures Flexible Multi‑Year Equity Financing Facility
Positive
Jun 17, 2026
On June 16, 2026, AIxCrypto Holdings, Inc. entered into a common shares purchase agreement with Gold King Arthur Holding Limited for a private placement of up to $50 million in common stock, capped at 19.99% of existing voting power unless shareho...
Business Operations and StrategyExecutive/Board Changes
AIxCrypto Holdings Reshapes Leadership and Refocuses Strategy
Negative
May 28, 2026
AIxCrypto Holdings announced a sweeping leadership reshuffle on May 21, 2026, with Co-Chief Executive Officer and director Kevin Richardson II, Chief Financial Officer and director Koti Meka, and President Campbell Becher all resigning, with Meka&...
Business Operations and StrategyPrivate Placements and Financing
AIxCrypto Shifts Marizyme Exposure to Royalty and Equity
Neutral
May 14, 2026
On May 12, 2026, AIxCrypto Holdings, Inc. entered into a note purchase agreement with CABG Acquisition Corp. to sell all of its rights in a note package tied to Marizyme, Inc., including an amended secured demand promissory note with about $4.77 m...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
AIxCrypto Reports Q1 Results Amid Strategic Transformation
Neutral
May 12, 2026
AIxCrypto Holdings reported its first-quarter 2026 results on May 11, 2026, marking its first full period operating under a strategic transformation completed in September 2025, and confirmed it remains pre-revenue while advancing three planned 20...
Business Operations and StrategyPrivate Placements and Financing
AIxCrypto Expands FFAI Investment via Amended Agreements
Positive
Apr 16, 2026
On April 10, 2026, AIxCrypto Holdings amended its entrusted investment agreement with GOLD KING ARTHUR HOLDING LIMITED and Song Wang to broaden the definition of Faraday Future Intelligent Electric Inc. (FFAI) assets covered to include preferred s...
Business Operations and StrategyDelistings and Listing ChangesFinancial DisclosuresPrivate Placements and FinancingProduct-Related Announcements
AIxCrypto advances AI, blockchain and RWA initiatives in 2026
Positive
Mar 27, 2026
In its inaugural full-year report as AIxCrypto Holdings, the company detailed its 2025 transformation from a biopharma business into an AI and blockchain infrastructure player, backed by a $41 million PIPE financing completed in September 2025 and...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.